83 related articles for article (PubMed ID: 14688060)
1. Paradoxical alteration of acute-phase protein levels in patients with chronic hepatitis C treated with IFN-alpha2b.
Kalabay L; Nemesánszky E; Csepregi A; Pusztay M; Dávid K; Horváth G; Ibrányi E; Telegdy L; Pár A; Bíró A; Fekete B; Gervain J; Horányi M; Ribiczey P; Csöndes M; Kleiber M; Walentin S; Prohászka Z; Füst G
Int Immunol; 2004 Jan; 16(1):51-4. PubMed ID: 14688060
[TBL] [Abstract][Full Text] [Related]
2. Changes in the acute phase complement component and IL-6 levels in patients with chronic hepatitis C receiving interferon alpha-2b.
Bíró L; Varga L; Pár A; Nemesánszky E; Csepregi A; Telegdy L; Ibrányi E; Dávid K; Horváth G; Szentgyörgyi L; Nagy I; Dalmi L; Abonyi M; Füst G; Horányi M
Immunol Lett; 2000 May; 72(2):69-74. PubMed ID: 10841940
[TBL] [Abstract][Full Text] [Related]
3. Lymphoblastoid interferon alfa-n1 improves the long-term response to a 6-month course of treatment in chronic hepatitis C compared with recombinant interferon alfa-2b: results of an international randomized controlled trial. Clinical Advisory Group for the Hepatitis C Comparative Study.
Farrell GC; Bacon BR; Goldin RD
Hepatology; 1998 Apr; 27(4):1121-7. PubMed ID: 9537453
[TBL] [Abstract][Full Text] [Related]
4. Effect of pegylated interferon alpha 2b plus ribavirin treatment on plasma transforming growth factor-beta1, metalloproteinase-1, and tissue metalloproteinase inhibitor-1 in patients with chronic hepatitis C.
Flisiak R; Jaroszewicz J; Lapinski TW; Flisiak I; Prokopowiczi D
World J Gastroenterol; 2005 Nov; 11(43):6833-8. PubMed ID: 16425392
[TBL] [Abstract][Full Text] [Related]
5. Interferon therapy for chronic hepatitis C in hemodialysis patients: increased serum levels of interferon.
Uchihara M; Izumi N; Sakai Y; Yauchi T; Miyake S; Sakai T; Akiba T; Marumo F; Sato C
Nephron; 1998 Sep; 80(1):51-6. PubMed ID: 9730703
[TBL] [Abstract][Full Text] [Related]
6. [Activation of acute phase proteins in patients with chronic hepatitis C treated with interferon-alpha 2a].
Łapiński TW
Pol Merkur Lekarski; 2001 Mar; 10(57):138-42. PubMed ID: 11398510
[TBL] [Abstract][Full Text] [Related]
7. Predictors of alpha-fetoprotein elevation in patients with chronic hepatitis C, but not hepatocellular carcinoma, and its normalization after pegylated interferon alfa 2a-ribavirin combination therapy.
Chen TM; Huang PT; Tsai MH; Lin LF; Liu CC; Ho KS; Siauw CP; Chao PL; Tung JN
J Gastroenterol Hepatol; 2007 May; 22(5):669-75. PubMed ID: 17444854
[TBL] [Abstract][Full Text] [Related]
8. Adiponectin levels among patients with chronic hepatitis B and C infections and in response to IFN-alpha therapy.
Lu JY; Chuang LM; Yang WS; Tai TY; Lai MY; Chen PJ; Kao JH; Lee CZ; Lee HS
Liver Int; 2005 Aug; 25(4):752-9. PubMed ID: 15998426
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of activated blood platelets by interferon alpha 2b in chronic hepatitis C.
Panasiuk A; Prokopowicz D; Zak J; Panasiuk B; Wysocka J
Hepatogastroenterology; 2004; 51(59):1417-21. PubMed ID: 15362767
[TBL] [Abstract][Full Text] [Related]
10. Predictive value of early virological response to treatment with different interferon-based regimens plus ribavirin in patients with chronic hepatitis C.
Napoli N; Giannelli G; Parisi CV; Antonaci A; Maddalena G; Antonaci S
New Microbiol; 2005 Jan; 28(1):13-21. PubMed ID: 15782622
[TBL] [Abstract][Full Text] [Related]
11. Serum levels of soluble interferon Alfa/Beta receptor as an inhibitory factor of interferon in the patients with chronic hepatitis C.
Mizukoshi E; Kaneko S; Kaji K; Terasaki S; Matsushita E; Muraguchi M; Ohmoto Y; Kobayashi K
Hepatology; 1999 Nov; 30(5):1325-31. PubMed ID: 10534358
[TBL] [Abstract][Full Text] [Related]
12. Kinetics of serum soluble tumour necrosis factor receptor (TNF-R) type-I and type-II after a single interferon-alpha (IFN-alpha) injection in chronic hepatitis C.
Fabris C; Del Forno M; Falleti E; Toniutto P; Pirisi M
Clin Exp Immunol; 1999 Sep; 117(3):556-60. PubMed ID: 10469062
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and tolerance of interferon-alpha(2b) in the treatment of chronic hepatitis C virus infection in haemodialysis patients. Pre- and post-renal transplantation assessment.
Campistol JM; Esforzado N; Martínez J; Roselló L; Veciana L; Modol J; Casellas J; Pons M; de Las Cuevas X; Piera J; Oliva JA; Costa J; Barrera JM; Bruguera M
Nephrol Dial Transplant; 1999 Nov; 14(11):2704-9. PubMed ID: 10534516
[TBL] [Abstract][Full Text] [Related]
14. Discordance between serum alanine aminotransferase (ALT) and virologic response to IFN-alpha2b in chronic hepatitis C patients with high and low pretreatment serum hepatitis C virus RNA titers.
Blatt LM; Tong MJ; McHutchison JG; Russell J; Schmid P; Conrad A
J Interferon Cytokine Res; 1998 Feb; 18(2):75-80. PubMed ID: 9506457
[TBL] [Abstract][Full Text] [Related]
15. Human fetuin/alpha2HS-glycoprotein level as a novel indicator of liver cell function and short-term mortality in patients with liver cirrhosis and liver cancer.
Kalabay L; Jakab L; Prohászka Z; Füst G; Benkö Z; Telegdy L; Lörincz Z; Závodszky P; Arnaud P; Fekete B
Eur J Gastroenterol Hepatol; 2002 Apr; 14(4):389-94. PubMed ID: 11943951
[TBL] [Abstract][Full Text] [Related]
16. Suppression of haematopoiesis during therapy of chronic hepatitis C with different interferon alpha mono and combination therapy regimens.
Schmid M; Kreil A; Jessner W; Homoncik M; Datz C; Gangl A; Ferenci P; Peck-Radosavljevic M
Gut; 2005 Jul; 54(7):1014-20. PubMed ID: 15951552
[TBL] [Abstract][Full Text] [Related]
17. [Effect of ribavirin on dynamics of hepatitis C viremia in interferon alpha-treated patiens with response or no response].
Berg T; Kaul T; Naumann U; Wiedenmann B; Hopf U
Z Gastroenterol; 2000 Nov; 38(11):881-6. PubMed ID: 11132533
[TBL] [Abstract][Full Text] [Related]
18. Evolution of hepatitis C virus-specific T cell responses and cytokine production in chronic hepatitis C patients treated with high doses of interferon-alpha.
Alvarado Esquivel C; Elewaut A; Philippé J; Elewaut AE; Desombere I; Maertens G; Leroux-Roels G
Rev Invest Clin; 2002; 54(1):41-50. PubMed ID: 11995406
[TBL] [Abstract][Full Text] [Related]
19. [Impact of interferon alpha immunotherapy on tryptophan metabolism in patients with chronic hepatitis C. Results of a pilot studies on ten patients].
Vignau J; Costisella O; Canva V; Imbenotte M; Duhamel A; Lhermitte M
Encephale; 2009 Oct; 35(5):477-83. PubMed ID: 19853722
[TBL] [Abstract][Full Text] [Related]
20. Cytokine regulation of the acute-phase protein levels in multiple myeloma.
Bíró L; Domján G; Falus A; Jakab L; Cseh K; Kalabay L; Tarkovács G; Tresch J; Malle E; Kramer J; Prohászka Z; Jákó J; Füst G; Császár A
Eur J Clin Invest; 1998 Aug; 28(8):679-86. PubMed ID: 9767364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
